U.S. License Holder:
Ferring
Date of License:
May-25-1995
Last Update:
Dec-15-2024
FDA-Approved Indications
ZOMACTON (somatropin) is a recombinant human growth hormone indicated for:
Pediatric: Treatment of pediatric patients with growth failure due to inadequate secretion of endogenous growth hormone (GH), short stature associated with Turner syndrome, idiopathic short stature (ISS), short stature or growth failure in short stature homeobox-containing gene (SHOX) deficiency, and short stature born small for gestational age (SGA) with no catch-up growth by 2 years to 4 years;
Adult: Replacement of endogenous GH in adults with GH deficiency.